Lanean...
Nicotinamide adenine dinucleotide suppresses epileptogenesis at an early stage
The pathophysiologic mechanisms of epileptogenesis are poorly understood, and no effective therapy exists for suppressing epileptogenesis. Numerous reports have shown that nicotinamide adenine dinucleotide (NAD(+)) has neuroprotective effects, suggesting its potential use for treating epileptogenesi...
Gorde:
| Argitaratua izan da: | Sci Rep |
|---|---|
| Egile Nagusiak: | , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Nature Publishing Group UK
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5544671/ https://ncbi.nlm.nih.gov/pubmed/28779137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-07343-0 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|